The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of pharmacist co-management for patients prescribed oral anticancer therapy for gastrointestinal cancers.
 
Cathy Cao
Stock and Other Ownership Interests - Abbvie (I); Abbvie (I); Abbvie (I); Abbvie (I); Johnson & Johnson (I); Johnson & Johnson (I); Johnson & Johnson (I); Johnson & Johnson (I)
Consulting or Advisory Role - UroGen pharma; UroGen pharma; UroGen pharma; UroGen pharma
 
James M. Cleary
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Research Funding - Merck; Merck; Merck; Merck; Tesaro; Tesaro; Tesaro; Tesaro
Travel, Accommodations, Expenses - Agios; Agios; Agios; Agios; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche; Roche; Roche; Roche
 
Anuj K. Patel
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai
Research Funding - Analysis Group (Inst); Analysis Group (Inst); Analysis Group (Inst); Analysis Group (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai
 
Matthew B. Yurgelun
No Relationships to Disclose
 
Kimmie Ng
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly; Seagen; Seagen; Seagen; Seagen; Tarrex Biopharma; Tarrex Biopharma; Tarrex Biopharma; Tarrex Biopharma
Research Funding - Celgene; Celgene; Celgene; Celgene; Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Pharmavite (Inst); Pharmavite (Inst); Pharmavite (Inst); Pharmavite (Inst); Trovagene; Trovagene; Trovagene; Trovagene
 
Kimberly Perez
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene
 
Douglas Adam Rubinson
Consulting or Advisory Role - Augmenix; Augmenix; Augmenix; Augmenix
 
Brian M. Wolpin
Honoraria - Celgene; Celgene; Celgene; Celgene; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics
Consulting or Advisory Role - BioLineRx; BioLineRx; BioLineRx; BioLineRx; Celgene; Celgene; Celgene; Celgene; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; G1 Therapeutics; Genentech; Genentech; Genentech; Genentech; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL; GRAIL
Research Funding - Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
 
Jeffrey A. Meyerhardt
Honoraria - Cota Healthcare; Cota Healthcare; Cota Healthcare; Cota Healthcare; Ignyta; Ignyta; Ignyta; Ignyta; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma
Research Funding - Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst)
 
Nadine Jackson McCleary
No Relationships to Disclose